Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]
Giriappa B +11 more
europepmc +1 more source
IAPSM's Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India. [PDF]
Rao CR +12 more
europepmc +1 more source
Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany. [PDF]
Heinemeier D +4 more
europepmc +1 more source
Cost-Effectiveness of the Pneumococcal Vaccine in the Adult Population: A Systematic Review. [PDF]
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc +1 more source
Serotype specific pneumococcal vaccine effectiveness in children with sickle cell disease: A two-decade analysis. [PDF]
Zhang Z +12 more
europepmc +1 more source
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18-64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8. [PDF]
Scott PT +15 more
europepmc +1 more source
Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024. [PDF]
Chan KF +5 more
europepmc +1 more source
Impact of the 13-valent pneumococcal vaccine on <i>Streptococcus pneumoniae</i> serotypes and antibiotic susceptibility in children. [PDF]
Shengxin Z +5 more
europepmc +1 more source
State of pneumococcal vaccine immunity. [PDF]
Akkoyunlu M.
europepmc +1 more source

